Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • The Last Word
  • Published:

Brazil's Stake in Biotechnology

Bio/Technology volume 13, page 818 (1995)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Heinz Redwood is an independent international pharmaceutical consultant specializing in corporate and industry strategy, and public policy issues. This article is excerpted from remarks he made at a seminar on intellectual property sponsored by Gazeta Mercantil in São Paulo last May. The full text and market models appear in Brazil: The Future Impact of Pharmaceutical Patents, 1995, distributed by CBS, 155 Hamilton Road, Felixstowe, Suffolk, U.K. Fax: 44 1394 271 348.

    • Heinz Redwood
Authors
  1. Heinz Redwood
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Redwood, H. Brazil's Stake in Biotechnology. Nat Biotechnol 13, 818 (1995). https://doi.org/10.1038/nbt0895-818

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0895-818

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing